Skip to main content
OpenTrials

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

320 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Urticaria trial results

Completed

Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

NCT06577116

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Site 601-004 Birmingham, Alabama, United States
  • Site 601-014 Bakersfield, California, United States
  • Site 601-015 Upland, California, United States
  • Site 601-006 Overland Park, Kansas, United States
View all 14 locations
View Trial Details
Completed

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

NCT04180488

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • California Allergy and Asthma Medical Group, Inc. Site Number : 8400019 Los Angeles, California, United States
  • Sarasota Clinical Research Site Number : 8400017 Sarasota, Florida, United States
  • Lenus Research & Medical Group Site Number : 8400001 Sweetwater, Florida, United States
  • University of South Florida Site Number : 8400006 Tampa, Florida, United States
View all 98 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site St Louis, Missouri, United States
  • Study Site Vienna, Austria
View all 19 locations
View Trial Details
Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

NCT06072157

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +11 more
Locations
  • Site 601-001 Healthy Volunteer Clinical Research Unit (Part A, B and D) Anniston, Alabama, United States
  • Site 601-004 (Part C) Birmingham, Alabama, United States
  • Site 601-008 (Part C) Scottsdale, Arizona, United States
  • Site 601-014 (Part C) Bakersfield, California, United States
View all 25 locations
View Trial Details
Completed

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

NCT05259917

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Little Rock, Arkansas, United States
  • KalVista Investigative Site San Diego, California, United States
View all 66 locations
View Trial Details
Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

NCT04208412

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Centennial, Colorado, United States
  • KalVista Investigative Site Chevy Chase, Maryland, United States
  • KalVista Investigative Site Cincinnati, Ohio, United States
View all 25 locations
View Trial Details
Completed

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

NCT04833855

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Avance Clinical Trials Laguna Niguel, California, United States
  • Jonathan Corren MD Inc Los Angeles, California, United States
View all 81 locations
View Trial Details
Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

NCT05030311

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site North Little Rock, Arkansas, United States
  • Novartis Investigative Site Bakersfield, California, United States
  • Novartis Investigative Site Lancaster, California, United States
View all 112 locations
View Trial Details

Related conditions